Elixinol Global Limited Annual Report 2020

Note 1: General information ................................................................................................................................................................................ 43 Note 2: Significant accounting policies .......................................................................................................................................................... 43 Note 3: Critical accounting judgements, estimates and assumptions ............................................................................................ 54 Note 4: Operating segments ............................................................................................................................................................................... 54 Note 5: Revenue ......................................................................................................................................................................................................... 57 Note 6: Other income............................................................................................................................................................................................... 57 Note 7: Expenses....................................................................................................................................................................................................... 58 Note 8: Income tax.................................................................................................................................................................................................... 60 Note 9: Discontinued operations........................................................................................................................................................................ 62 Note 10: Cash and cash equivalents................................................................................................................................................................... 65 Note 11: Trade and other receivables ................................................................................................................................................................ 65 Note 12: Inventories.................................................................................................................................................................................................... 66 Note 13: Prepayments, deposits and other...................................................................................................................................................... 67 Note 14: Investments accounted for using the equity method.............................................................................................................. 67 Note 15: Property, plant and equipment.......................................................................................................................................................... 70 Note 16: Right-of-use assets ................................................................................................................................................................................... 72 Note 17: Intangibles..................................................................................................................................................................................................... 73 Note 18: Trade and other payables....................................................................................................................................................................... 74 Note 19: Contract liabilities...................................................................................................................................................................................... 75 Note 20: Borrowings .................................................................................................................................................................................................... 75 Note 21: Lease liabilities ............................................................................................................................................................................................ 76 Note 22: Issued capital ............................................................................................................................................................................................... 76 Note 23: Reserves ......................................................................................................................................................................................................... 77 Note 24: Non-controlling interest......................................................................................................................................................................... 77 Note 25: Dividends....................................................................................................................................................................................................... 77 Note 26: Financial instruments .............................................................................................................................................................................. 77 Note 27: Fair value measurement ........................................................................................................................................................................ 80 Note 28: Remuneration of auditors.................................................................................................................................................................... 80 Note 29: Contingent liabilities ............................................................................................................................................................................... 80 Note 30: Commitments ............................................................................................................................................................................................. 81 Note 31: Key management personnel disclosures ....................................................................................................................................... 81 Note 32: Related party transactions .................................................................................................................................................................... 81 Note 33: Business combinations .......................................................................................................................................................................... 83 Note 34: Interests in subsidiaries.......................................................................................................................................................................... 84 Note 35: Deed of cross guarantee ....................................................................................................................................................................... 84 Note 36: Cash flow information.............................................................................................................................................................................. 87 Note 37: Earnings per share.................................................................................................................................................................................... 88 Note 38. Share-based payments .......................................................................................................................................................................... 89 Note 39: Parent entity information....................................................................................................................................................................... 91 Note 40: Events after the reporting period ..................................................................................................................................................... 92 F INANCI AL REPORT 42 Elixinol Global Limited | Annual Report 2020 Notes to the Consolidated Financial Statements for the year ended 31 December 2020